Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 21096 | 999 | 0.9631 | 1.0000 | 0.0474 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 22233 | 990 | 1.0180 | 1.0000 | 0.0445 | 0.0468 |
A-375 | Vemurafenib | (+)-JQ1 | 0.000 | 0.000 | uM | 72 | hr | 2 | 14840 | 1490 | 0.9441 | 1.0000 | 0.1004 | 0.0814 |
A-375 | Vemurafenib | (+)-JQ1 | 0.000 | 0.000 | uM | 72 | hr | 1 | 17083 | 736 | 1.1561 | 1.0000 | 0.0431 | 0.0814 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 1 | 15089 | 638 | 0.9090 | 1.0016 | 0.0423 | 0.0383 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 2 | 16836 | 650 | 1.0181 | 1.0016 | 0.0386 | 0.0383 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 17737 | 603 | 1.0777 | 1.0016 | 0.0340 | 0.0383 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 1676 | 108 | 1.2009 | 1.0853 | 0.0644 | 0.0619 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1253 | 76 | 0.9015 | 1.0853 | 0.0607 | 0.0619 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 1603 | 97 | 1.1534 | 1.0853 | 0.0605 | 0.0619 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 2014 | 89 | 1.1861 | 1.1047 | 0.0442 | 0.0462 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1508 | 67 | 0.8879 | 1.1047 | 0.0444 | 0.0462 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 2119 | 106 | 1.2403 | 1.1047 | 0.0500 | 0.0462 |
MZ7-mel | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 4690 | 306 | 0.9633 | 1.1499 | 0.0652 | 0.0651 |
MZ7-mel | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 6060 | 359 | 1.2527 | 1.1499 | 0.0592 | 0.0651 |
MZ7-mel | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 6042 | 428 | 1.2336 | 1.1499 | 0.0708 | 0.0651 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 2 | 1398 | 83 | 1.3314 | 1.2926 | 0.0594 | 0.0509 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 1 | 1207 | 52 | 1.1694 | 1.2926 | 0.0431 | 0.0509 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 3 | 1432 | 72 | 1.3770 | 1.2926 | 0.0503 | 0.0509 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 1846 | 89 | 1.4019 | 1.3011 | 0.0482 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 1771 | 79 | 1.3500 | 1.3011 | 0.0446 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1511 | 68 | 1.1513 | 1.3011 | 0.0450 | 0.0459 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 1 | 1158 | 56 | 1.0822 | 1.3028 | 0.0484 | 0.0415 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 1476 | 60 | 1.3905 | 1.3028 | 0.0407 | 0.0415 |